vinpocetine has been researched along with Retinal Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, ML; Kalloniatis, M; Khoo, P; Nivison-Smith, L | 2 |
| Acosta, ML; Guo, CX; Kalloniatis, M; Nivison-Smith, L; O'Brien, BJ; Truong, M | 1 |
| Imre, G; Németh, B | 1 |
| Oláh, Z; Potocký, M | 1 |
| Imre, G | 1 |
6 other study(ies) available for vinpocetine and Retinal Diseases
| Article | Year |
|---|---|
Vinpocetine protects inner retinal neurons with functional NMDA glutamate receptors against retinal ischemia.
Topics: Animals; Calbindin 2; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Ischemia; Kainic Acid; Neuroprotective Agents; Parvalbumins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Retinal Diseases; Retinal Neurons; Retinal Vessels; Vinca Alkaloids | 2018 |
Vinpocetine modulates metabolic activity and function during retinal ischemia.
Topics: Animals; Cell Death; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Energy Metabolism; Ependymoglial Cells; Evoked Potentials; Glucose; Glutamic Acid; Ischemia; L-Lactate Dehydrogenase; Neuroprotective Agents; Rats, Sprague-Dawley; Retinal Diseases; Tissue Culture Techniques; Vinca Alkaloids | 2015 |
Pre-treatment with vinpocetine protects against retinal ischemia.
Topics: Animals; Calbindin 2; Calcium Channel Blockers; Disease Models, Animal; Ependymoglial Cells; Immunohistochemistry; Ischemia; Microscopy, Confocal; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Retinal Neurons; Vinca Alkaloids | 2017 |
The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
Topics: Cerebrovascular Circulation; Double-Blind Method; Humans; Retinal Diseases; Vascular Resistance; Vasodilator Agents; Vinca Alkaloids; Vincamine | 1981 |
[Treatment of vascular retinal lesions with Cavinton (author's transl)].
Topics: Aged; Female; Humans; Male; Middle Aged; Retinal Diseases; Vinca Alkaloids | 1981 |
Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis.
Topics: Anterior Eye Segment; Humans; Infusions, Intravenous; Ischemia; Optic Nerve Diseases; Retinal Artery; Retinal Diseases; Vinca Alkaloids | 1986 |